{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"iBio, Inc."},"Symbol":{"label":"Symbol","value":"IBIO"},"Address":{"label":"Address","value":"8800 HSC PARKWAY,SUITE 1601, BRYAN, Texas, 77807-1107, United States"},"Phone":{"label":"Phone","value":"+1 302 355-0650"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"iBio Inc is a part of the healthcare sector. Its main business is commercialized technologies and product candidates and manufacturing services to clients and collaborators. Its main area of business is plant-based protein expression technologies for vaccines and therapeutic proteins and developing and commercializing select biopharmaceutical product candidates. Its products are used to combat various areas such as fibrotic diseases, cancers, and infectious diseases. The company operates in two segments: biologics development and licensing activities, conducted within iBio, Inc."},"CompanyUrl":{"label":"Company Url","value":"https://www.ibioinc.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Martin B. Brenner","title":"Director, Chief Executive & Scientific Officer"},{"name":"Matthew Luter","title":"Vice President-Information Technology"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}